Skip to content

Intraoperative wound irrigation to prevent surgical site infection after laparotomy

Intraoperative wound irrigation to prevent surgical site infection after laparotomy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2017-000152-26-DE
Enrollment
680
Registered
2017-04-26
Start date
2017-06-27
Completion date
Unknown
Last updated
2022-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To investigate whether the use of intraoperative, epifascial wound irrigation with polyhexanide (PHX) solution can reduce surgical site infections (SSI) after laparotomy for visceral surgery compared to saline irrigation or no irrigation.

Interventions

Pharmaceutical Form: Irrigation solution INN or Proposed INN: POLIHEXANIDE CAS Number: 32289-58-0 Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: 1000- Pharmaceuti

Sponsors

Technische Universität München Fakultät für Medizin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Clean-contaminated, contaminated or dirty surgery according to Centre for Disease Control (CDC) classification; • Abdominal surgery by midline or transverse laparotomy; elective and emergency procedures; • Age = 18 years; • American Society of Anesthesiologists (ASA) score = 3; • Ability to understand the nature and extent of the trial and to give written informed consent; Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 300 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 240

Exclusion criteria

Exclusion criteria: • Pregnancy or breast feeding; • Known hypersensitivity/allergy to PHX; • Inability to understand/give informed consent; • ASA >3; • Critical medical condition of emergency patients, precluding informed consent or sufficient time to reflect on the decision to participate in the trial • Inability to attend follow-up visits; • Clean procedures according to the CDC classification or surgery without opening of the abdominal cavity; • Laparoscopic surgery; • Revision-surgery (previous abdominal surgery within the last 30 days); • Planned re-laparotomy within 30 days; • Severe immunosuppression; • Concurrent abdominal wall infections; • Pre-operative antibiotic therapy (within 5 days prior to surgery) except for emergencies due to septic peritonitis • Participation in another clinical trial that interferes with the primary or secondary outcomes of this trial

Design outcomes

Primary

MeasureTime frame
Main Objective: To investigate whether the use of intraoperative, epifascial wound irrigation with polyhexanide (PHX) solution can reduce surgical site infections after laparotomy for visceral surgery compared to saline irrigation or no irrigation.;Secondary Objective: not applicable;Primary end point(s): SSI according to CDC criteria within 30 days postoperatively;Timepoint(s) of evaluation of this end point: 30 days

Secondary

MeasureTime frame
Secondary end point(s): • Non-infectious wound complications (e.g. seroma, hematoma, delayed healing) within 30 days postoperatively • Duration of hospital stay • Mortality and morbidity within 30 days postoperatively • Incidence of reoperation within 30 days postoperatively • Incidence of AE/SAE within 30 days postoperatively ;Timepoint(s) of evaluation of this end point: 30 days

Countries

Germany

Contacts

Public ContactKlinik und Poliklinik für Chirurgie

Technische Universität München Klinikum rechts der Isar

daniel.reim@tum.de0049(0)8941405019

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026